U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats
about
Kappa opioids as potential treatments for stimulant dependenceNeurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodentsKappa-opioid ligands in the study and treatment of mood disordersNaltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in HumansNeurobiology of aversive states.Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?Cyclazocine revisitedEffects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys.Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules.Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticityKappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependenceModulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.Virus-mediated shRNA knockdown of prodynorphin in the rat nucleus accumbens attenuates depression-like behavior and cocaine locomotor sensitization.Regulation of neurotransmitter interactions in the ventral striatum.Bi- or multifunctional opioid peptide drugs.Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeysRole of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in ratsThe role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuseAge-dependent effects of kappa-opioid receptor stimulation on cocaine-induced stereotyped behaviors and dopamine overflow in the caudate-putamen: an in vivo microdialysis study.The role of kappa-opioid receptor activation in mediating antinociception and addiction.Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in miceEffect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats.The kappa opioid receptor: from addiction to depression, and back.Effects of the mixed mu/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men.Pharmacotherapy of addictions.Development and in vitro characterization of a novel bifunctional μ-agonist/δ-antagonist opioid tetrapeptide.Effects of the selective delta opioid agonist SNC80 on cocaine- and food-maintained responding in rhesus monkeysThe long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) ratsKappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration.Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system.Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.The role of the dynorphin/κ opioid receptor system in anxiety.Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation.The mu/kappa agonist nalbuphine attenuates sensitization to the behavioral effects of cocaineDevelopment of κ opioid receptor antagonists.Effects of dorsal striatal infusions of R(-)-propylnorapomorphine on kappa-opioid-mediated locomotor activity in the young rat: possible role of the indirect pathway.Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate.Hypothesis-driven medication discovery for the treatment of psychostimulant addictionThe effects of repeated opioid administration on locomotor activity: II. Unidirectional cross-sensitization to cocainekappa-Opioid receptor signaling and brain reward function
P2860
Q24647849-E10A6FFE-60E6-4BB1-8879-0B19304E9926Q24656267-CB32FFAD-BEAD-4586-B881-27D166D3F2F1Q24657982-747DE566-FB19-4920-AA48-4436C2725A69Q27300685-53926280-D737-433F-B2B2-DE19D3BBC68DQ27687846-2A2130CF-6937-465B-A3D8-3232C513DE74Q28259148-EBE4BF3E-E605-4AFF-B887-AF5354FA0B9AQ28298711-575B180C-8B48-4344-8451-DE347119545FQ30362023-E9E59445-B47A-425D-902D-C608C82133D4Q30428091-7931E736-FD3A-47E9-8319-2B76EDC758DEQ30435816-B7CF042A-6AA7-4DA6-AF42-70A45DC90894Q30453617-9C92BF23-6036-4254-9E0D-138562C2CD6AQ31911309-08864F31-0AA9-4938-8905-149078B5C98EQ33591477-1DF18914-3AAA-404E-8EA7-B0CF51C80169Q33692750-D26B5DF8-302E-4A9C-B538-2DF48181B954Q33767037-32C4E78F-7972-4B7E-8186-B4F854752F18Q33817945-6C229BBA-AEF3-4E1A-B5B4-CCE2248064B8Q33848200-150A2B19-4D45-4E82-9E18-DD5FCFB41393Q33890721-8792BA4F-FE24-4CFB-86BE-10FBDF7E2C5FQ33976326-BAC54E44-6551-441B-A077-4D9F46B5AE81Q34132638-4567A016-3258-4F34-97C5-B08FF79551F2Q34436340-2C494CBE-69A3-4871-B03B-21BE93F733FCQ34493780-C1F6D00C-B109-4D07-83A4-CAF5A6BF0E0DQ34650892-B4F2C048-7126-4269-8C5F-EA24091219F4Q34803483-00336539-A1AD-4DF2-84D9-5C28DF1FA267Q34810395-011D3B06-76E5-47ED-8E48-22774993523BQ35621534-0755B723-EA89-4BAF-B48E-FD1C5739FFDDQ35748384-ACAD3B31-D392-45FC-BD46-A1672AFF03AAQ35892525-81197A3A-96D3-4696-806E-0B6838E3DD94Q35985799-A1A5E9C2-195A-4B6F-8192-A18DFCB3B9B0Q36101215-B4ED1917-3D8B-4702-9826-9E021BA402C2Q36174266-8FD2C6BC-8973-4125-B3A1-4A75D10F80DEQ36287728-18A3E655-BD51-4ABE-B5A1-3D426CE1DC13Q36554599-6BDC406C-8B18-422F-858B-AAE5E07616F0Q36709875-8CD138C5-3955-4043-819D-0AE618FA42FFQ36728154-404AD212-A251-4F95-99D8-86B1A32D9F14Q37069774-C1478DEE-0FD4-4E4B-A8E9-B2AFDEF27590Q37130532-6BEB853A-3AE6-4A3A-8559-010FC9F8D784Q37183687-B4BC6145-A4E1-47F5-8C12-56873D21FBF8Q37267987-3A2E11AE-B83F-4BD1-95BB-47708560C206Q37455456-782D84D0-3D0C-4D08-98CB-CED9C342F258
P2860
U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
U50,488, a kappa opioid recept ...... the nucleus accumbens of rats
@ast
U50,488, a kappa opioid recept ...... the nucleus accumbens of rats
@en
U50,488, a kappa opioid recept ...... the nucleus accumbens of rats
@nl
type
label
U50,488, a kappa opioid recept ...... the nucleus accumbens of rats
@ast
U50,488, a kappa opioid recept ...... the nucleus accumbens of rats
@en
U50,488, a kappa opioid recept ...... the nucleus accumbens of rats
@nl
prefLabel
U50,488, a kappa opioid recept ...... the nucleus accumbens of rats
@ast
U50,488, a kappa opioid recept ...... the nucleus accumbens of rats
@en
U50,488, a kappa opioid recept ...... the nucleus accumbens of rats
@nl
P2093
P921
P1433
P1476
U50,488, a kappa opioid recept ...... the nucleus accumbens of rats
@en
P2093
I M Maisonneuve
P356
10.1016/0304-3940(94)90559-2
P407
P577
1994-11-07T00:00:00Z